Congenital disorders of glycosylation: State of the art and Spanish experience;Defectos congénitos de la glucosilación: Últimos avances y experiencia Española

Medicina Clinica

Volumn 122, Issue 18, 2004, Pages 707-716

  Vilaseca, María Antonia ^a   Artuch, Rafael ^a   Briones, Paz ^b  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b Institut de Bioquimica Clinica Barcelona   (Spain)

Author keywords

CDG; Congenital disorders of glycosylation; N glycosylation; O glycosylation

Indexed keywords

ACETYLSALICYLIC ACID; BISPHOSPHONIC ACID DERIVATIVE; MANNOSE; PHOSPHOMANNOMUTASE;

CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONGENITAL DISORDER OF GLYCOSYLATION; CYTOSOL; ENDOPLASMIC RETICULUM; ENTEROPATHY; ENZYME ANALYSIS; GENETIC DISORDER; GLYCOPROTEIN SYNTHESIS; GLYCOSYLATION; HUMAN; LIVER DISEASE; MUSCULAR DYSTROPHY; NERVE CELL; PROTEIN PROCESSING; REVIEW; SPAIN;

EID: 2942567868     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13062172     Document Type: Review

References (99)

1. Jaeken J, Matthijs G. Congenital disorders of glycosylation. Ann Rev Genomics Hum Genet 2001;2:129-51.
2. Jaeken J. Komrower lecture. Congenital disorders of glycosylation (CDG): it's all in it! J Inherit Metab Dis 2003;26:99-118.
3. Schachter H. Congenital disorders involving defective N-glycosylation of proteins. Cell Mol Life 2001;58:1085-104.
4. Spiro RG. Protein glycosylation: nature, distribution, enzymatic formation and disease implications of glycopeptide bonds. Glycobiology 2002;12: 43R-56R.
5. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 1985;54:631-64.
6. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993;3:97-130.
7. Jaeken J, Vanderschueren-Lodeweyckx M, Casaer P, Snoeck L, Corbeel L, Eggermont E, et al. Familial psychomotor retardation with markedly fluctuating serum proteins, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome? Pediatr Res 1980;14:179.
8. Van Eijk HG, Van Noort WL, Dubelaar M-L, Van der Heul C. The microheterogeneity of human transferrins in biological fluids. Clin Chim Acta 1983;132:167-71.
9. Participants, First International Workshop on CDGS, Leuven, Belgium (1999). Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. Glycobiology 1999;10:3-6.
10. Aebi M, Helenius A, Schenk B, Barone R, Fiumara A, Berger EG, et al. Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS. Glycoconj J 1999;16:669-71.
11. Van Schaftingen E, Jaeken J. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett 1995;377:318-20.
12. Martinsson T, Bjursell C, Stibler H, Kristiansson B, Skovby F, Jaeken J, et al. Linkage of a locus for carbohydrate-deficient glycoprotein syndrome type I (CDG1) to chromosome 16p, and linkage disequilibrium to microsatellite marker D16S406. Hum Mol Genet 1994;3:2037-42.
13. Matthijs G, Schollen E, Pardon E, Veiga-Da-Cunha M, Jaeken J, Cassiman JJ, et al. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet 1997;16:88-92.
14. Marquardt T, Denecke J. Congenital disorders of glycosylation: review of their molecular bases, clinical presentation and specific therapies. Eur J Pediatr 2003;162:359-79.
15. Imtiaz F, Worthington V, Champion M, Besley C, Charlwood J, Clayton P, et al. Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1. J Inherit Metab Dis 2000;23:162-74.
16. Jaeken J, Stibler H, Hagberg B. The carbohydrate-deficient glycoprotein syndrome. A new inherited multisystemic disease with severe nervous system involvement. Acta Paediatr Scand 1991;375:1-71.
17. Jaeken J, Carchon H. The carbohydrate-deficient glycoprotein syndromes: an overview. J Inherit Metab Dis 1993;16:813-20.
18. De Zegher F, Jaeken J. Endocrinology of the carbohydrate-deficient glycoprotein syndrome type 1 from birth through adolescence. Pediatr Res 1995;37:395-401.
19. Stibler H, Blennow G, Kristiansson B, Lindehammer H, Hagberg B. Carbohydrate-deficient glycoprotein syndrome: clinical expression in adults with a new metabolic disease. J Neurol Neurosurg Psy 1994;57:552-6.
20. Briones P, Vilaseca MA, Schollen E, Ferrer I, Maties M, Busquets C, et al. Biochemical and molecular studies in 26 Spanish patients with congenital disorder of glycosylation type Ia. J Inherit Metab Dis 2002; 25:635-46.
21. Pancho C, García-Cazorla A, Varea V, Artuch R, Vilaseca MA, Briones P, et al. Congenital disorder of glycosylation type Ia revealed by hypertransaminemia and fallure to thrive in a young boy with normal neurodevelopment [en prensa]. J Pediatr Gastr Nutr.
22. Niehues R, Hasilik M, Alton G, Körner C, Schiebe-Sukumar M, Koch HG, et al. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest 1998;101:1414-20.
23. De Koning TJ, Dorland L, Van Diggelen OP, Boonman AM, De Jong GJ, Van Noort WL, et al. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. Biochem Biophys Res Comm 1998; 245:38-42.
24. Jaeken J, Matthijs G, Saudubray JM, Dionisi-Vici C, Bertini E, De Lonlay P, et al. Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet 1998;62:1535-9.
25. De Lonlay P, Cuer M, Vuillaumier-Barrot S, Beaune G, Castelnau P, Kretz M, et al. Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: a new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. J Pediatr 1999;135:379-83.
26. Babovic-Vuksanovic D, Patterson MC, Schwenk WF, O'Brien JF, Vockley J, Freeze HH, et al. Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome. J Pediatr 1999;135: 775-81.
27. Burda P, Borsig L, De Rijk-van Andel J, Wevers R, Jaeken J, Carchon H, et al. A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide. J Clin Invest 1998;102:647-52.
28. Körner C, Knauer R, Holzbach U, Hanefeld F, Lehle L, Von Figura K. Carbohydrate-deficient glycoprotein syndrome type V: deficiency of dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase. Proc Natl Acad Sci 1998;95:13200-5.
29. Grünewald S, Imbach T, Huijben K, Rubio-Gozalbo ME, Verrips A, De Klerk JB, et al. Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis. Ann Neurol 2000;47:776-81.
30. Hanefeld F, Körner C, Holzbach-Eberle U, Von Figura K. Congenital disorder of glycosylation-Ic: case report and genetic defect. Neuropediatrics 2000;31:60-2.
31. Körner C, Knauer R, Stephani U, Marquardt T, Lehle L, Von Figura K. Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man5GlcNAc2-PP-dolichyl mannosyltransferase. Embo J 1999;18:6816-22.
32. Stibler H, Stephani U, Kutsch U. Carbohydrate-deficient glycoprotein syndrome - a fourth subtype. Neuropediatrics 1995;26:235-7.
33. Imbach T, Schenk B, Schollen E, Burda P, Stutz A, Grünewald S, et al. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. J Clin Invest 2000;105:233-9.
34. Kim S, Westphal V, Srikrishna G, Mehta DP, Peterson S, Filiano J, et al. Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation le (CDG-Ie). J Clin Invest 2000;105:191-8.
35. Garcia Silva MT, Briones P, Schollen E, Cabrera JL, Sánchez del Pozo J, Martí Herreros M, et al. Congenital disorder of glycosylation (CDG) type Ie. A new patient. J Inherit Metab Dis 2002;25:133.
36. Kranz C, Denecke J, Lehrman MA, Ray S, Kienz P, Kreissel G, et al. A mutation in the human MPDU1 gene causes congenital disorder of glycosylation If (CDG-If). J Clin Invest 2001;108:1613-9.
37. Thiel C, Schwarz M, Hasilik M, Grieben U, Hanefeld F, Lehle L, et al. Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation-Ig. Biochem J 2002; 367:195-201.
38. Chantret I, Dancourt J, Dupre T, Delenda C, Bucher S, Vuillaumier-Barrot S, et al. A deficiency in dolichyl-P-glucose: Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation. J Biol Chem 2003;278:9962-71.
39. Thiel C, Schwarz M, Peng J, Grzmil M, Hasilik M, Braulke T, et al. A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. J Biol Chem 2003;278:22498-505.
40. Wu X, Rush JS, Karaoglu D, Krasnewich D, Lubinsky MS, Waechter CJ, et al. Deficiency of UDP-GlcNAc: dolichol phosphate N-acetylglucosamine-1 phosphate transferase (DPAGT1) causes a novel congenital disorder of glycosylation type Ij. Hum Mutat 2003;22:144-50.
41. Ramaekers VT, Stibler H, Kint J, Jaeken J. A new variant of the carbohydrate deficient glycoproteins syndrome. J Inherit Metab Dis 1991;14: 385-8.
42. Jaeken J, De Cock P, Stibler H, Van Geet C, Kint J, Ramaekers V, et al. Carbohydrate-deficient glycoprotein syndrome type II. J Inherit Metab Dis 1993;16:1041.
43. Fukuda MN, Dell A, Scartezzini P. Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan-proteins caused by lowered N-acetylglucosaminyltransferase II. J Biol Chem 1987;262:7195-206.
44. Schachter H, Jaeken J. Carbohydrate-deficient glycoprotein syndrome type II. Biochim Biophys Acta 1999;1455:179-92.
45. Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G. Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. Arch Dis Child 1994; 71:123-7.
46. Charuk JH, Tan J, Bernardini M, Haddad S, Reithmeier RA, Jaeken J. Carbohydrate-deficient glycoprotein syndrome type II. An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS). Eur J Biochem 1995;230:797-805.
47. Tan J, Dunn J, Jaeken J, Schachter H. Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. Am J Hum Genet 1996;59:810-7.
48. De Praeter CM, Gerwig GJ, Bause E, Nuytinck LK, Vliegenthart JF, Breuer W, et al. A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. Am J Hum Genet 2000;66:1744-56.
49. Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JC, et al. Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 1992;327:1789-92.
50. Marquardt T, Brune T, Luhn K, Zimmer KP, Körner C, Fabritz L, et al. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism. J Pediatr 1999;134:681-8.
51. Lübke T, Marquardt T, Von Figura K, Körner C. A new type of carbohydrate-deficient glycoprotein syndrome due to a decreased import of GDP-fucose into the Golgi. J Biol Chem 1999;274:25986-9.
52. Körner C, Linnebank M, Koch HG, Harms E, Von Figura K, Marquardt T. Decreased availability of GDP-L-fucose in a patient with LAD II with normal GDP-D-mannose dehydratase and FX protein activities. J Leukoc Biol 1999;66:95-8.
53. Hanbke B, Thiel C, Lübke T, Hasilik M, Höning S, Peters V, et al. Deficiency of UDP-galactose: N-acetylglucosamine b-1,4-galactosyltransferase I as a cause of the congenital disorder of glycosylation type IId (CDG-IId). J Clin Invest 2002;109:725-33.
54. Dorland L, De Koning TJ, Toet M, De Vries LS, Van den Berg IET, Poll-The BT. Recurrent non-immune hydrops fetalis associated with carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis 1997;20:88.
55. Eyskens F, Ceuterick C, Martin JJ, Janssens G, Jaeken J. Carbohydrate-deficient glycoprotein syndrome with previously unreported features. Acta Paediatr 1994;83:892-6.
56. Acarregui MJ, George TN, Rhead WJ. Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities. J Pediatr 1998;133:697-700.
57. Charlwood J, Clayton P, Johnson A, Keir G, Mian N, Winchester B. A case of the carbohydrate-deficient glycoprotein syndrome type 1 (CDGS type 1) with normal phosphomannomutase activity. J Inherit Metab Dis 1997;20:817-26.
58. Skladal D, Sperl W, Henry H, Bachmann C. Congenital cataract and familial brachydactyly in carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis 1996;19:251-2.
59. Knopf C, Rod R, Jaeken J, Berant M, Van Schaftingen E, Fryns JP, et al. Transferrin protein variant mimicking carbohydrate-deficient glycoprotein syndrome in trisomy 7 mosaicism. J Inherit Metab Dis 2000;23:399-403.
60. Fletcher M, Matthijs G, Jaeken J, Van Schaftingen E, Nelson PV. Carbohydrate-deficient glycoprotein syndrome: beyond the screen. J Inherit Metab Dis 2000;23:396-8.
61. Stibler H, Von Dobeln U, Kristiansson B, Guthenberg C. Carbohydrate-deficient transferrin in galactosaemia. Acta Paediatr 1997;86:1377-8.
62. Jaeken J, Pirard M, Adamowicz M, Pronicka E, Van Schaftingen E. Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance. Pediatr Res 1996;40:764-6.
63. Adamowicz M, Pronicka E. Carbohydrate deficient glycoprotein syndrome-like transferrin isoelectric focusing pattern in untreated fructosaemia. Eur J Pediatr 1996;155:347-8.
64. Charlwood J, Clayton P, Keir G, Mian N, Winchester B. Defective galactosylation of serum transferrin in galactosemia. Glycobiology 1998;8: 351-7.
65. Landberg E, Pahlsson P, Lundblad A, Arnetorp A, Jeppsson JO. Carbohydrate composition of serum transferrin isoforms from patients with high alcohol consumption. Biochem Biophys Res Comm 1995;210:267-74.
66. Grunewald S, Schollen E, Van Schaftingen E, Jaeken J, Matthijs G. High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency). Am J Hum Genet 2001;68:347-54.
67. Kjaergaard S, Skovby F, Schwartz M. Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1. Eur J Hum Genet 1998;6:331-6.
68. Kjaergaard S, Skovby F, Schwartz M. Carbohydrate-deficient glycoprotein syndrome type 1A: expression and characterisation of wild type and mutant PMM2 in E. coli. Eur J Hum Genet 1999;7:884-8.
69. Bjursell C, Wahlstrom J, Berg K, Stibler H, Kristiansson B, Matthijs G, et al. Detailed mapping of the phosphomannomutase 2 (PMM2) gene and mutation detection enable improved analysis for Scandinavian CDG type I families. Eur J Hum Genet 1998;6:603-11.
70. Vuillaumier-Barrot S, Barnier A, Cuer M, Durand G, Grandchamp B, Seta N. Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate- deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping. Hum Mutat 1999;14:543-44.
71. Kondo I, Mizugishi K, Yoneda Y, Hashimoto T, Kuwajima K, Yuasa I, et al. Missense mutations in phosphomannomutase 2 gene in two Japanese families with carbohydrate-deficient glycoprotein syndrome type 1. Clin Genet 1999;55:50-4.
72. Crosby A, Jeffery S, Homfray T, Taylor R, Patton M. Prenatal diagnosis and the subsequent mutation analysis in a family with carbohydrate-deficient glycoprotein type I syndrome: growing evidence to support founder effects within CDG 1 populations. Genet Test 1999;3:305-7.
73. Matthijs G, Schollen E, Heykants L, Grünewald S. Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia). Mol Genet Metab 1999;68:220-6.
74. Matthijs G, Schollen E, Van Schaftingen E, Cassiman JJ, Jaeken J. Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A. Am J Hum Genet 1998;62:542-50.
75. Pirard M, Matthijs G, Heykants L, Schollen E, Grünewald S, Jaeken J, et al. Effect of mutations found in carbohydrate-deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2. FEBS Lett 1999; 452:319-22.
76. Schollen E, Kjaergaard S, Legius E, Schwartz M, Matthijs G. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorder of glycosylation type Ia). Eur J Hum Genet 2000;8:367-71.
77. Schollen E, Dorland L, De Koning TJ, Van Diggelen OP, Huijmans JG, Marquardt T, et al. Genomic organization of the human phospomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib). Hum Mut 2000;16:247-52.
78. Imbach T, Burda P, Kuhnert P, Wevers RA, Aebi M, Berger EG, et al. A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic. Proc Natl Acad Sci 1999;96:6982-7.
79. Imbach T, Grünewald S, Schenk B, Burda P, Schollen E, Wevers R, et al. Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic. Hum Genet 2000;106:538-45.
80. Matthijs G, Schollen E, Cassiman JJ, Cormier-Daire V, Jaeken J, Van Schaftingen E. Prenatal diagnosis in CDG1 families: beware of heterogeneity. Eur J Hum Genet 1998;6:99-104.
81. Clayton P, Winchester B, Di Tomaso E, Young E, Keir G, Rodeck C. Carbohydrate-deficient glycoprotein syndrome: normal glycosylation in the fetus. Lancet 1993;341:956.
82. Stibler H, Skovby F. Failure to diagnose carbohydrate-deficient glycoprotein syndrome prenatally. Pediatr Neurol 1994;11:71.
83. Coddeville B, Carchon H, Jaeken J, Briand G, Spik G. Determination of glycan structures and molecular masses of the glycovariants of serum transferrin from a patient with carbohydrate deficient syndrome type II. Glycoconj J 1998;15:265-73.
84. Panneerselvam K, Etchison JR, Skovby F, Freeze HH. Abnormal metabolism of mannose in families with carbohydrate-deficient glycoprotein syndrome type 1. Biochem Mol Med 1997;61:161-7.
85. Mayatepek E, Schröder M, Kohlmüller D, Bieger WP, Nützenadel W. Continuous mannose infusion in carbohydrate-deficient glycoprotein syndrome type I. Acta Paediatr 1997;86:1138-40.
86. Mayatepek E, Kohlmüller D. Mannose supplementation in carbohydrate-deficient glycoprotein syndrome type I and phosphomannomutase deficiency. Eur J Pediatr 1998;157:605-6.
87. Körner C, Lehle L, Von Figura K. Carbohydrate-deficient glycoprotein syndrome type 1: correction of the glycosylation defect by deprivation of glucose or supplementation of mannose. Glycoconj J 1998;15:499-505.
88. Van Geet C, Jaeken J, Freson K, Lenaerts T, Arnout J, Vermylen J, et al. Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications. J Inherit Metab Dis 2001;24:477-92.
89. Alton G, Kjaergaard S, Etchison JR, Skovby F, Freeze HH. Oral ingestion of mannose elevates blood mannose levels: a first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome type I. Biochem Mol Med 1997;60:127-33.
90. Freeze HH, Aebi M. Molecular basis of carbohydrate-deficient glycoprotein syndromes type I with normal phosphomannomutase activity. Biochim Biophys Acta 1999;1455:167-78.
91. Niehues R, Hasilik M. Carbohydrate-deficient glycoprotein syndrome (CDGS) type Ib. A hereditary metabolic disease and its therapy. MMW Fortschr Med 2000;142:171-2.
92. Okajima T, Fukumoto S, Furukawa K, Urano T, Furukawa K. Molecular basis for the progeroid variant of Ehlers-Danlos syndrome. J Biol Chem 1999;274:28841-4.
93. Wuyts W, Van Hul W. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Hum Mutat 2000;15:220-7.
94. Muntoni F, Brockington M, Blake DJ, Torelli S, Brown SC. Defective glycosylation in muscular dystrophy. Lancet 2002;360:1419-21.
95. Cormand B, Pihko H, Bayes M, Valanne L, Santavouri P, Talim B, et al. Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology 2001;56:1059-69.
96. Beltran-Valero de Bernabé D, Currier S, Steinbrecher A, Celli J, Van Beusekom E, Van der Zwaag B, et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2002;71:1033-43.
97. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JF, et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 2002;418:417-22.
98. Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Ishihara T, Nonaka I, et al. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 2001;57:115-21.
99. Brockington M, Yura Y, Prandini P, Brown SC, Torelli S, Benson MA, et al. Mutations in the Fukutin related protein gene (FKRP) identifies limb-girdle muscular dystrophy 21 as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 2001;10:2851-9.